CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy.
Möckel D, Bartneck M, Niemietz P, Wagner M, Ehling J, Rama E, Weiler M, Gremse F, Eulberg D, Pola R, Pechar M, Etrych T, Storm G, Kiessling F, Tacke F, Lammers T.
Möckel D, et al. Among authors: etrych t.
J Control Release. 2024 Jan;365:358-368. doi: 10.1016/j.jconrel.2023.11.044. Epub 2023 Nov 30.
J Control Release. 2024.
PMID: 38016488